Midazolam, an alternative anesthetic induction agent, demonstrated a slower onset compared to thiopentone but presented fewer cardiovascular and local side effects. Despite longer-lasting apnea, differences had no significant clinical impact, establishing midazolam as a viable option.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: